Mehrotra Parth 4

What Happened Parth Mehrotra, CEO of Privia Health Group, sold 21,097 shares in an open-market transaction on 2026-03-10 for total proceeds of approximately $479,113 (weighted average price $22.71). Around the same time he was credited with awards/vesting of a total of 313,246 shares: 141,342 restricted stock units (RSUs) granted 2026-03-10 and 171,904 shares distributed upon vesting of performance stock units (PSUs) on 2026-03-11. The sale is a disposal (not a purchase); the awards are compensation/vesting events (no cash paid).

Key Details

• Sale: 21,097 shares on 2026-03-10; weighted average price $22.71; prices ranged $22.27–$23.23; total proceeds ≈ $479,113. (Footnote F2)
• Awards/Vesting: 141,342 RSUs granted 2026-03-10 (vest in substantially equal annual installments; F3) and 171,904 shares distributed 2026-03-11 reflecting vested PSUs from prior grants (F4). Total awarded/vested: 313,246 shares.
• Sale executed under a pre-arranged Rule 10b5-1 trading plan (Footnote F1).
• Shares owned after these transactions are not specified in the provided excerpt of the filing.
• Filing date: 2026-03-12 for transactions on 2026-03-10 and 2026-03-11 — filing appears timely.

Context Sales made under a 10b5-1 plan are pre-arranged and often routine; they do not necessarily signal a change in insider view. The RSUs are subject to time-based vesting, while the PSUs reflect performance-based vesting for the 2023–2025 period. For investors, outright purchases are generally a stronger bullish signal than sales or routine compensation-related awards.